A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Conditions:   Age-Related Macular Degeneration;   Allergies;   Alpha-Gal Syndrome;   Alzheimer Disease;   Amyloidosis;   Ankylosing Spondylitis;   Arthritis;   Alopecia Areata;   Asthma;   Atopic Dermatitis;   Autism;   Autoimmune Hepatitis;   Behcet's Disease;   Beta-Thalassemia;   Can cer;   Celiac Disease;   Kidney Diseases;   COPD;   Crohn Disease;   Cystic Fibrosis;   Diabetes;   Dravet Syndrome;   DMD;   Fibromyalgia;   Graves Disease;   Thyroid Diseases;   Hepatitis;   Hidradenitis Suppurativa;   ITP;   Leukemia;   ALS;   Lupus or SLE;   Lymphoma;   Multiple Scle...
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials

Effects of the Nottingham Augmented Reality (AR) App for Arthritis Hand Joint Pain
Conditions:   Chronic Pain;   Arthritis Hand;   Opioid Use Interventions:   Other: Standard of care;   Device: Nottingham AR smartphone app with active intervention Sponsors:   VRx Medical Inc;   National Institute on Drug Abuse (NIDA);   San Diego Veterans Healthcare System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Conditions:   Age-Related Macular Degeneration;   Allergies;   Alpha-Gal Syndrome;   Alzheimer Disease;   Amyloidosis;   Ankylosing Spondylitis;   Arthritis;   Alopecia Areata;   Asthma;   Atopic Dermatitis;   Autism;   Autoimmune Hepatitis;   Behcet's Disease;   Beta-Thalassemia;   Can cer;   Celiac Disease;   Kidney Diseases;   COPD;   Crohn Disease;   Cystic Fibrosis;   Diabetes;   Dravet Syndrome;   DMD;   Fibromyalgia;   Graves Disease;   Thyroid Diseases;   Hepatitis;   Hidradenitis Suppurativa;   ITP;   Leukemia;   ALS;   Lupus or SLE;   Lymphoma;   Multiple Scle...
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials

Effects of the Nottingham Augmented Reality (AR) App for Arthritis Hand Joint Pain
Conditions:   Chronic Pain;   Arthritis Hand;   Opioid Use Interventions:   Other: Standard of care;   Device: Nottingham AR smartphone app with active intervention Sponsors:   VRx Medical Inc;   National Institute on Drug Abuse (NIDA);   San Diego Veterans Healthcare System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
Condition:   Psoriatic Arthritis Interventions:   Drug: Guselkumab;   Drug: Golimumab Sponsors:   University of Pennsylvania;   Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)
Condition:   Psoriatic Arthritis Intervention:   Behavioral: Telemedicine Sponsor:   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
Condition:   Psoriatic Arthritis Interventions:   Drug: Guselkumab;   Drug: Golimumab Sponsors:   University of Pennsylvania;   Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)
Condition:   Psoriatic Arthritis Intervention:   Behavioral: Telemedicine Sponsor:   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
Condition:   Psoriatic Arthritis Interventions:   Drug: Guselkumab;   Drug: Golimumab Sponsors:   University of Pennsylvania;   Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)
Condition:   Psoriatic Arthritis Intervention:   Behavioral: Telemedicine Sponsor:   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
Condition:   Psoriatic Arthritis Interventions:   Drug: Guselkumab;   Drug: Golimumab Sponsors:   University of Pennsylvania;   Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Persona 0 ° Keel Randomized Controlled Trial
Conditions:   Knee Pain Chronic;   Rheumatoid Arthritis;   Osteoarthritis;   Traumatic Arthritis;   Polyarthritis;   Avascular Necrosis;   Varus Deformity;   Valgus Deformity;   Flexion Deformity of Knee Interventions:   Device: Cementless Persona 0° Knee System;   Device: Cemented Persona 0° Knee System Sponsor:   Zimmer Biomet Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials